• BioRestorative Therapies received the immediate resignation of Silva as vice president of research and development on Sept. 4, 2026.
• Silva also resigned from any other officer roles he held at the company.
• The board acknowledged the resignation for corporate-records and disclosure purposes, while disputing claims tied to the departure.
• A board-directed investigation by special counsel is reviewing the negotiation, execution, and amendment of the disputed employment agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-099018), on September 11, 2026, and is solely responsible for the information contained therein.